Today Opko Health agreed to buy Bio-Reference Laboratories for $1.47 billion in OPK stock. Frost is CEO and Chairman of OPK. I can only speculate on whether or not he has any future plans in regard to ATNM.
Actinium Announces $5 Million Registered Direct Offering of Common Stock
Excerpt from today's press release: "Under the terms of the subscription agreements, the Company will issue an aggregate of 1,923,078 shares of the Company's common stock at a purchase price of $2.60 per share. The offering is expected to close on or about June 10, 2015, subject to the satisfaction of customary closing conditions. This financing was led by investor Dr. Phillip Frost."